Implications of mutational analysis for the management of patients with gastrointestinal stromal tumors and the application of targeted therapies.

Implications of mutational analysis for the management of patients with gastrointestinal stromal tumors and the application of targeted therapies.

Item
http://www.wikidata.org/entity/Q37778380
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications.Sunitinib as first-line neoadjuvant therapy in two patients with rectal stromal tumors.Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal stromal tumor.Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report.Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib.
P2860

Implications of mutational analysis for the management of patients with gastrointestinal stromal tumors and the application of targeted therapies.

Item
http://www.wikidata.org/entity/Q37778380
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Implications of mutational ana ...... ication of targeted therapies.
@en
Implications of mutational ana ...... ication of targeted therapies.
@nl
type
label
Implications of mutational ana ...... ication of targeted therapies.
@en
Implications of mutational ana ...... ication of targeted therapies.
@nl
prefLabel
Implications of mutational ana ...... ication of targeted therapies.
@en
Implications of mutational ana ...... ication of targeted therapies.
@nl
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Implications of mutational ana ...... ication of targeted therapies.
@en
P2860
P304
P31
P356
10.3109/07357907.2010.494322
P433
P478
P50
P577
P5875
P698